Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Hangzhou Tigermed Technology Co., Ltd. is a Chinese contract research organization providing whole process clinical trial services for the research and development of pharmaceutical products.Since its inception, the company is dedicated to the provision of medical research and development services that enables clients to reduce the risk and cost of R&D, while advancing the process of marketization. With 21 sub-companies spread across 43 main cities in the world, including China, America, Canada, Japan, Australia, Korea, and more, Tigermed owns a professional team of more than 900 people that constructs the operating instruction that meets international standards. Tigermed has succeeded in providing more than 300 customers with over 300 clinical trial services by the end of 2013. For its participation in 42 domestic drugs, Tigermed is honoured as an “Innovation-type CRO.”
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 9, 2020
3D Medicines
|
Series Unknown | $140M | Biopharma | — |